Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (hereinafter referred to as Wantai) belongs to the Yang Sheng Tang Co., Ltd., was listed in Shanghai Stock Exchange in 2020, and are engaged in the development and production of the biological diagnostic reagents and vaccines. Wantai developed the world's first Hepatitis E vaccine, first Chinese HPV vaccine and nasal spray type COVID-19 vaccine. At the same time, we are also one of major manufacturers of immunodiagnostic reagents in China and a large production base of infectious diseases diagnostics in the Asia-pacific region. Our facilities are GMP, ISO9001 and ISO13485 certified and our products undergo strict quality and cost controls. Almost all of our core raw materials are developed and supplied by Wantai ourself, therefore our supply chain is very stable.
Instruments
Reagents
Here is an opportunlty to contact and meet other potentlal companles or partners.
If you are interested in booking a stand at CACLP, please leave your details below and one of our representatives will be in touch soon.
Copyright © 2024 GL events Ruihe (Shanghai) Exhibition Co., Ltd. All Rights Reserved. ( 沪ICP备12004745号-1 )
We deliver the latest IVD news straight to your inbox. Stay in touch with CACLP News.
sign-up for our newsletter today.
To ensure our newsletter hit your inbox, make sure to add @caclp.com to your safe senders list. And, as always, feel free to contact
us with any questions and thanks again for subscribing.
Go back
